1.
glioblastoma multiform
多形性胶质母细胞瘤
2.
MR Findings of Uncommon site Glioblastoma
少见部位胶质母细胞瘤的MRI表现
3.
Intracranial glioblastoma:a clinicopathologic analysis of 51 cases
颅内胶质母细胞瘤51例临床病理分析
4.
MRI Features after Resection of Glioblastoma and Their Significance
胶质母细胞瘤术后MRI特征及其意义
5.
Construction of the stable Smad7 transfecting glioblastoma cell lines
Smad7稳定转染胶质母细胞瘤细胞系的建立
6.
One case of glioblastoma with brain metastases in cerebellopontine angle area
颅内桥小脑角区胶质母细胞瘤合并转移瘤1例
7.
Experimental Study of Treatment of Intracranial G422 Glioblastoma with Bone Marrow-derived Dendritic Cells Pulsed With Tumor Extracts;
肿瘤提取物冲击致敏树突状细胞治疗G422胶质母细胞瘤的实验研究
8.
Sensitivity of Brain Tumor Stem Cells from Multiform Glioblastomas to ~(60)Co γ-ray in Vitro
~(60)Coγ射线对多形性胶质母细胞瘤中的肿瘤干细胞的影响
9.
Isolation,culture and biological characteristics of tumor stem cells in human brain glioblastoma
胶质母细胞瘤肿瘤干细胞的分离培养与生物学特性研究
10.
Apoptosis-inducing Therapy for Glioblastoma and the Underlying Molecular Mechanism
胶质母细胞瘤诱导凋亡治疗及其机制研究
11.
Change in Expression Profile of Immune-related Gene in Glioblastoma Tissues before and after Radiotherapy
胶质母细胞瘤放射治疗前后免疫相关基因研究
12.
Expression Profile of Glioblastoma Tissue beforeandafter Radiotherapy of 60Gy and Its Significance
IGLV1-44、SLPI、CXCL14在胶质母细胞瘤放疗前后表达及意义
13.
Study on Differentiation Effect of Glioblastoma Cell Line BT325 Induced by Arsenic Trioxide;
三氧化二砷诱导胶质母细胞瘤细胞分化作用的研究
14.
Study of Apoptosis Induced by Arsenic Trioxide in BT-325 Cells;
三氧化二砷诱导胶质母细胞瘤细胞凋亡作用的研究
15.
Experimental Study of the Regulation of Tissue Factor on Doxorubicin-induced Apoptosis in Human Glioblastoma;
组织因子调控阿霉素诱导人胶质母细胞瘤细胞凋亡的研究
16.
Targeted Blockage of STAT3 Signaling Pathway with JSI-124 Inhibits the Proliferation of Human Glioblastoma Multiforme Cells in Vitro;
阻断STAT3信号通路对人脑胶质母细胞瘤细胞增殖抑制的实验研究
17.
Study on Molecular Mechanism of Resistance to TRAIL-induced Apoptosis in Glioblastoma Cells and Glioblastoma Stem Cells
胶质母细胞瘤及其干细胞抵抗TRAIL诱导凋亡分子机制的研究
18.
Value Evaluation of Hepatocyte Growth Factor Receptor in Glioblastoma Postoperation Radiotherapy
肝细胞生长因子受体在胶质母细胞瘤术后放疗过程中的价值评价